STOCK TITAN

DAXOR CORP (DXR) CFO adds 1,000 shares in open-market buy

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

DAXOR CORP Chief Financial Officer Michel Robert J reported an open-market purchase of Daxor Common Stock. On March 31, 2026, he bought 1,000 shares at $9.90 per share, bringing his directly held stake to 21,050 shares after the transaction.

Positive

  • None.

Negative

  • None.
Insider Michel Robert J
Role Chief Financial Officer
Bought 1,000 shs ($10K)
Type Security Shares Price Value
Purchase Daxor Common Stock 1,000 $9.90 $10K
Holdings After Transaction: Daxor Common Stock — 21,050 shares (Direct)
Footnotes (1)
Shares purchased 1,000 shares Open-market purchase on March 31, 2026
Purchase price $9.90 per share Transaction price for Daxor Common Stock
Shares held after 21,050 shares Direct holdings after the reported transaction
Net shares bought 1,000 shares Net buy direction in transaction summary
open-market purchase financial
"transaction_action": "open-market purchase""
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
Daxor Common Stock financial
""security_title": "Daxor Common Stock""
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Chief Financial Officer financial
""officer_title": "Chief Financial Officer""
A Chief Financial Officer (CFO) is the person in charge of a company's money and financial planning. They decide how to spend, save, and invest funds to help the company grow and stay stable. Their role is important because good financial decisions keep the company healthy and successful.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Michel Robert J

(Last)(First)(Middle)
109 MECO LANE

(Street)
OAK RIDGE, TENNESSEE 37830

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
DAXOR CORP [ DXR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Daxor Common Stock03/31/2026P1,000A$9.921,050D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
/s/ Robert J. Michel03/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did DAXOR CORP (DXR) report for Michel Robert J?

DAXOR CORP reported that Chief Financial Officer Michel Robert J made an open-market purchase of Daxor Common Stock. He bought 1,000 shares on March 31, 2026, as a direct holding, according to the Form 4 filing details.

How many DAXOR CORP (DXR) shares did the CFO buy and at what price?

The CFO bought 1,000 shares of Daxor Common Stock in an open-market purchase. The transaction price was $9.90 per share, as disclosed in the Form 4 insider trading report filed for this transaction.

What are Michel Robert J’s DAXOR CORP (DXR) holdings after this Form 4 trade?

Following the reported transaction, Chief Financial Officer Michel Robert J directly holds 21,050 shares of Daxor Common Stock. This figure reflects his position immediately after purchasing 1,000 shares on March 31, 2026, in the open market.

Was the DAXOR CORP (DXR) insider transaction a purchase or a sale?

The transaction was a purchase. The Form 4 describes an open-market purchase of Daxor Common Stock, coded as a “P” transaction, with a buy direction, indicating acquisition of 1,000 shares at $9.90 per share.

Is the DAXOR CORP (DXR) CFO’s ownership direct or indirect after this transaction?

The Form 4 indicates the CFO’s ownership as direct. The ownership code is listed as “D,” and the nature of ownership shows this as a direct holding of 21,050 Daxor Common Stock shares following the reported transaction.
DAXOR CORP

NASDAQ:DXR

View DXR Stock Overview

DXR Rankings

DXR Latest News

DXR Latest SEC Filings

DXR Stock Data

56.52M
2.97M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
NEW YORK